Horizon Discovery Group (HZD)
HZD Share PerformanceMore
|52 week high||188.05 29/04/16|
|52 week low||104.00 30/11/16|
|52 week change||21.50 (14.58%)|
|4 week volume||3,966,428 28/01/17|
Media for (HZD)
Latest News« previous» nextMore
23/02/2017 - 07:00 RNS
RNS Number: 6123X Horizon Discovery Group plc 23 February 2017 Horizon Discovery ("Horizon" or the "Group") Site Visit Cambridge, UK, 23 February 2017: Horizon Discovery Group plc (LSE: HZD), the world leader in the application of gene editing technologies, is hosting a site visit at its corporate headquarters for institutional investors today and for sell-side a...
20/02/2017 - 13:21 RNS
RNS Number: 3275X Horizon Discovery Group plc 20 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Horizon Discovery Group Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of vo...
16/02/2017 - 16:43 Interactive Investor
After a poor 2016, star fund manager Neil Woodford lagged the wider market again in January. He's also been bargain hu...
15/02/2017 - 09:10 StockMarketWire
Beaufort Securities today reaffirms its speculative buy investment rating on Horizon Discovery Group Plc (LON:HZD) an...
15/02/2017 - 07:00 RNS
RNS Number: 8896W Horizon Discovery Group plc 15 February 2017 15 February 2017 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 2,777 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 2,777 new ordinary shares to be admitted to trading on AIM and it is expe...
14/02/2017 - 07:28 StockMarketWire
Horizon Discovery Group has signed a master services agreement with a top three global pharmaceutical company, extend...
14/02/2017 - 07:00 RNS
RNS Number: 7719W Horizon Discovery Group plc 14 February 2017 Horizon Discovery Signs a Master Service Agreement with a Top Three Pharmaceutical Company Cambridge, UK, 14 February 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Group"), the world leader in the application of gene editing technologies, today announces the signing o...
10/02/2017 - 07:00 RNS
RNS Number: 4783W Horizon Discovery Group plc 10 February 2017 10 February 2017 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 11,306 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 11,306 new ordinary shares to be admitted to trading on AIM and it is expe...
|Dividend yield||0 %|
Latest discussion posts More
“4 dir + 100,000. Dr Johnathan Milner non ex +90,000. Founder of Abacam & Pharma superstar. Woodford also a holder”▼
“From Citywire: "?Biologic? era benefits Horizon Discovery, says Numis Gene-editing company Horizon Discovery (HZDH) has improved efficiency and is driving its product ...”▼
“"An announcement this morning sees Horizon expand the application of its bioproduction cell line platform with new partnerships with the Centre for Process Innovation (CPI, UK) ...”▼
Codes & Symbols
|Symbols||HZD, LSE:HZD, HZD.L, HZD:LN, LON:HZD, XLON:HZD|